100+ PHARMACY Research Topics for Thesis or Dissertation

good dissertation or thesis topic is one that allow you to research, write and produce a piece of unique work within a limited amount of time and resources. One of the most important factors in choosing picking a thesis topic is to work on something that you really love, keep you engage and interested so you can focus on it till the successful defense of your dissertation.
If you are a pharmacy student or anything related to chemical or medicine then we have shortlisted some topics that you can choose for your dissertation or thesis. You can select few topics and show to your supervisor for their recommendations. Remember, you select the topic that you are sure about it’s timely completion.

  1. Docking analysis of nonstructural protein (NSP) inhibitors on SARS-CoV-2 related NSP intracellular reception sites.
  2. Computer aided molecular designing (CAMD), Docking studies and Denovo Synthesis of optimized and chemioselective inhibitors on SARS-CoV-2 related ACEII reception sites on surface of cell.
  3. Denovo Synthesis and computer aided molecular designing (CAMD) of optimized and chemioselective inhibitors on SARS-CoV-2 related serine protease reception sites.
  4. Computer aided molecular designing (CAMD), binding energy analysis and Denovo Synthesis of chemioselective antiviral drug molecules for HIV related intracellular protease inhibition.
  5. Chemioselective antiviral drug molecules for HEP-C related intracellular reception sites: Computer aided molecular designing (CAMD), Docking studies and Denovo Synthesis
  6. Antiviral drug molecules for HIV related entry or fusion inhibition: Computer aided molecular designing (CAMD), Docking studies and Denovo Synthesis.
  7. Molecular structural characterization and stereochemical analysis of novel polycyclic microtubule disassembly inhibitor drug molecules using two dimensional 2D-NMR COSY techniques.
  8. Two dimensional 2D-NMR HETCOR techniques for molecular structural characterization and stereochemical analysis of novel polycyclic microtubule disassembly inhibitor drug molecules
  9. 2D-NMR NOESY techniques for novel polycyclic microtubule disassembly inhibitor drug molecules.
  10. pH dependent chemioselective binding interaction and optimization of molecular structure of known anti-HIV protease inhibitors on SARS-CoV-2 related intracellular reception sites.
  11. Anti HPV protease inhibitors on SARS-CoV-2 related reception sites: Chemioselective binding interaction and optimization of molecular structure.
  12. Binding interaction and molecular structural optimization of known protease inhibitors on SARS-CoV-2 related intracellular reception sites.
  13. Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant behavior of Selegiline derivatives.
  14. Known anti SARS-COV protease inhibitors on SARS-CoV-2 related intracellular reception sites: Docking interaction and Computer aided optimization of molecular structure for chemioselective interactions.
  15. MALDI-TOF HR-MS techniques for fragmentation analysis of novel polycyclic microtubule disassembly inhibitor drug molecules.
  16. FAB and SIMS HR-MS techniques for molecular structural characterization and fragmentation analysis of novel polycyclic microtubule disassembly inhibitor drug molecules.
  17. Bridged polycyclic derivatives of Norborane microtubule assembly blocker drug molecules: Two dimensional 2D-NMR COSY techniques for molecular structural characterization and stereochemical analysis.
  18. Molecular structural characterization and stereochemical analysis of optimized norborane microtubule assembly blocker drug molecules using two dimensional 2D-NMR HETCOR techniques.
  19. Fragmentation analysis of optimized norborane microtubule assembly blocker drug molecules using FAB and SIMS HR-MS techniques.
  20. Polyamide Imidazole pyrrole-based drug delivery vehicle bonded chemotherapeutic heterocyclic alkylating agents for chemioselective crosslinking of DNA strands: Design, Synthesis, Characterization.
  21. Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant behavior of Tyrosol derivatives.
  22. Minor groove binding polyamide Imidazole pyrrole-based drug delivery vehicle bonded epoxide based alkylating agents for chemioselective crosslinking of DNA strands.
  23. Design, Synthesis, Characterization of Polyamide Imidazole pyrrole-based drug delivery vehicle bonded chemotherapeutic N-Mustard based alkylating agents.
  24. Alkyl sulfonate alkylating agents for chemioselective crosslinking of DNA strands: Design, Synthesis, Characterization and combination with Polyamide Imidazole pyrrole-based drug delivery vehicle.
  25. 2D-NMR NOESY techniques for molecular structural characterization and stereochemical analysis of optimized norborane assembly blocker drug molecules.
  26. MALDI-TOF HR-MS techniques for fragmentation analysis of optimized norborane assembly blocker drug molecules using MALDI-TOF HR-MS techniques.
  27. Neurological molecular drug delivery vehicle to cross Blood Brain barrier: Design, Synthesis, Characterization of Linear chain molecules.
  28. Molecular drug delivery vehicle to cross Blood Brain barrier: Design, Synthesis, Characterization of cyclic ring chain molecules.
  29. Neurological molecular drug delivery vehicle of optimization of polymeric carriers for folic acid drug delivery
  30. Taxane family molecular drug stability and relationship with relaxation times in the solid-state NMR.
  31. T1 and T2 relaxation times in the solid-state NMR and alkaloids molecular drug stability.
  32. Antimetabolites molecular drug stability analysis using solid-state NMR.
  33. Molecular structural stability of biosynthesis enzyme inhibitors
  34. Receptor antagonists: Analysis of structure and relationship with stability through relaxation times in the solid-state NMR.
  35. Organometallic cisplatin drug molecules: Conformational analysis in various polar solvents and at different pH. 
  36. Dicycloplatin molecular structural drug stability.
  37. Relationship between relaxation times in the solid-state NMR and microtubule assembly molecular drug stability.
  38. Computer aided molecular designing (CAMD), development and structural optimization of polymeric carriers for purine drug delivery peptide molecules to cross Blood Brain barrier: Design, Synthesis, Characterization.
  39. Drug delivery vehicle to cross Blood Brain barrier: Design, Synthesis, Characterization of organometallic amino acid molecules for neurological applications.
  40. Polyamide Imidazole pyrrole-based drug delivery vehicle bonded chemotherapeutic cisplatin alkylating agents for chemioselective crosslinking of DNA strands: Design, Synthesis, Characterization.
  41. Derivatives of oxyplatin alkylating agents for chemioselective crosslinking of DNA strands: Design, Synthesis, Characterization.
  42. Relationship between relaxation times in the solid-state NMR and alkylating agent molecular drug stability.
  43.  A study on Folic acid molecular drug:  Relationship between relaxation times in the solid-state NMR and stability.
  44. Computer aided molecular designing (CAMD), optimization and development of polymeric carriers for Taxane drug delivery
  45. Alkaloid based polymeric carriers drug delivery system: Molecular Design, optimization, and systhesis. 
  46. A study on pyrimidine-based drug delivery system: Design, development and structural optimization
  47. Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant behavior of Oleocanthal derivatives
  48. Molecular design, retrosynthesis, characterization and drug solvent properties of pyridinium Ionic Liquid molecules.
  49. Computer aided drug designing (CADD), retrosynthesis, characterization and drug solvent properties of imidazolium Ionic Liquid molecules.
  50. A study on thiophene Ionic Liquid molecules: theoretical designing, retrosynthesis, characterization and drug solvent properties.
  51. Antioxidant study of (ALCAR)Alpha-lipoic acid derivatives: Computer aided drug designing (CADD) and radical reaction simulation.
  52. Piperidinium Ionic Liquid molecules: Molecular structure optimization, retrosynthesis, characterization and application as drug molecule.
  53. Design, development and structural optimization of polymeric carriers for treosulfan drug – delivery
  54. Design, development and structural optimization of polymeric carriers for busulfan drug delivery
  55. Molecular designing, development and structural optimization of polymeric carriers for N-Mustard drug delivery
  56. Design, ddevelopment and structural optimization of polymeric carriers for Cisplatin drug delivery
  57. Structural optimization of polymeric carriers:  Designing, development and application as drug delivery.
  58. Theoretical design, retrosynthesis, characterization and drug solvent properties of furan based Ionic Liquid molecules.
  59. Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant behavior of Carotenoids (vitamin A) derivatives Theoretical design, retrosynthesis, characterization and drug solvent properties of ammonium Ionic Liquid molecules.
  60. Pyrrole Ionic Liquid molecules: Computer aided drug designing (CADD), retrosynthesis, characterization and drug solvent properties.
  61. A study on imidazolium derivative based Ionic Liquid: Theoretical design, retrosynthesis, characterization and drug solvent properties of imidazolium derivative based Ionic Liquid molecules.
  62. Molecular design, retrosynthesis, characterization and drug solvent properties of pyridinium with different counter ions Ionic Liquid molecules.
  63. Computer aided drug designing (CADD), retrosynthesis, characterization and drug solvent properties of phosphonium Ionic Liquid molecules.   
  64. Acetyl-L-carnitine derivatives: Molecular structural optimization and radical reaction simulation of antioxidant behavior.
  65. Molecular designing and simulation of antioxidant behavior of (ALA)Ascorbic acid (vitamin C) derivatives.
  66. Molecular structural optimization and radical reaction simulation of antioxidant behavior of Ladostigil derivatives.
  67. A study on Melatonin derivative: Computer aided molecular designing (CAMD) and radical reaction simulation as antioxidant behavior.
  68. Mofegiline derivatives: Computer aided molecular designing (CAMD) and radical reaction simulation as antioxidant.
  69. Molecular structural optimization and radical reaction simulation of antioxidant behavior of N-Acetylcysteine (NAC) derivatives.
  70. A study on N-Acetylserotonin (NAS) derivatives: Computer aided molecular designing (CAMD) and radical reaction simulation as antioxidant behavior.
  71. Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant behavior of Rasagiline derivatives.
  72. Antioxidant behavior of Curcumin derivatives: Computer aided molecular designing (CAMD) of optimized derivatives and radical reaction simulation.
  73. A study of Edaravone derivatives: Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant behavior.
  74. Molecular structural optimization and radical reaction simulation of antioxidant behavior of Polyphenols derivatives.
  75. Glutathione derivatives: Molecular structural optimization and radical reaction simulation of antioxidant behavior.
  76. Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant behavior of Hydroxytyrosol derivatives.
  77. L-carnitine derivatives Molecular structural optimization and radical reaction simulation of antioxidant behavior.
  78. Ubiquinone (coenzyme Q) derivatives: Computer aided molecular designing (CAMD) and radical reaction simulation as antioxidant.
  79. Computer aided molecular designing (CAMD) of Uric acid derivatives and their radical reaction simulation of antioxidant.
  80. Novel structural derivatives of Coumarins and impact of structural change on controlled or optimized anticoagulant properties.
  81. A study on novel structural derivatives of Acenocoumarol and impact of structural change on anticoagulant properties  
  82. optimized anticoagulant properties Novel structural derivatives of Coumatetralyl
  83. Novel structural derivatives of Dicoumarol and impact of structural change on controlled or optimized anticoagulant properties.
  84. Novel structural derivatives of Diphenadione: Impact of structural changes on control or optimization of anticoagulant properties
  85. Control or optimization of anticoagulant properties of Novel derivatives of Phenindione through structural change.
  86. anticoagulant properties of novel Tioclomarol derivatives and structural impact on anticoagulant properties
  87. Potential of derivatives of Cilostazol Phosphodiesterase inhibitors as antiplatelet drugs
  88.  Triflusal Phosphodiesterase inhibitors and their derivatives study as antiplatelet agents.
  89. Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant behavior of Oleuropein derivatives.
  90. Potential of derivatives of Dipyridamole Phosphodiesterase inhibitors as antiplatelet drugs.
  91. Resveratrol derivatives: Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant
  92. Designing and synthesis of derivatives of ethyl biscoumacetate and impact of structural change on anticoagulant properties.
  93. Optimized anticoagulant properties novel structural derivatives of Phenprocoumon.
  94. Warfarin: Novel structural derivatives and impact of structural change on anticoagulant properties.
  95. Selenium Tocopherols (vitamin E) derivatives: Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant.
  96. Novel structural derivatives of diones and their optimized anticoagulant properties.
  97. Tocotrienols (vitamin E) derivatives: Computer aided molecular designing (CAMD) and radical reaction simulation of antioxidant.
  98. 1,3-Indandiones: Structural derivatives and impact of structural change on controlled or optimized anticoagulant properties.
  99. Novel structural derivatives of Clorindione and impact of structural change on controlled or optimized anticoagulant properties.
  100. Novel imidazole biphenyl derivatives for ACE and ACE II receptor site inhibition.

Get tips and advice on everything from finding a mentor and choosing a topic to getting your Dissertation /thesis/ research writing done.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.